ClinVar Miner

Submissions for variant NM_032119.4(ADGRV1):c.7006C>T (p.Arg2336Ter)

dbSNP: rs527236133
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000844604 SCV000731305 pathogenic Rare genetic deafness 2016-11-23 criteria provided, single submitter clinical testing The p.Arg2336X variant in GPR98 has been previously reported in 1 Chinese indivi dual with Usher syndrome who was compound heterozygous for a second truncating v ariant in GPR98 (Jiang 2015). This variant has not been identified in large pop ulation studies. This nonsense variant leads to a premature termination codon at position 2336, which is predicted to lead to a truncated or absent protein. Los s of GPR98 function is an established disease mechanism in autosomal recessive U sher syndrome. In summary, this variant meets criteria to be classified as patho genic for autosomal recessive Usher syndrome based upon the predicted impact to the protein.
Invitae RCV001849954 SCV002245919 pathogenic not provided 2022-07-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg2336*) in the ADGRV1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADGRV1 are known to be pathogenic (PMID: 19357117, 22135276, 22147658, 26226137, 30718709, 31047384, 32467589). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 143160). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 26338283).
Neuberg Supratech Reference Laboratories Pvt Ltd, Neuberg Centre for Genomic Medicine RCV000132687 SCV002820234 pathogenic Usher syndrome type 2C criteria provided, single submitter clinical testing The stop gained p.R2336* in ADGRV1 (NM_032119.4) has been previously reported in 1 Chinese individual with Usher syndrome (Jiang et al, 2015). This variant is predicted to cause loss of normal protein function through protein truncation. The p.R2336* variant is a loss of function variant in the gene ADGRV1, which is intolerant of Loss of Function variants. The amino acid change p.Arg2336Ter in ADGRV1 is predicted as conserved by GERP++ across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic.
Department of Ophthalmology and Visual Sciences Kyoto University RCV000132687 SCV000172640 probable-pathogenic Usher syndrome type 2C no assertion criteria provided not provided Converted during submission to Likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.